Department of Immunology and Inflammation, IRCCS Humanitas Clinical Institute, Via Manzoni 56, 20089, Rozzano, Milan, Italy.
Exp Cell Res. 2011 Mar 10;317(5):664-73. doi: 10.1016/j.yexcr.2010.11.013. Epub 2010 Dec 4.
Chemokines are key players of the cancer-related inflammation. Chemokine ligands and receptors are downstream of genetic events that cause neoplastic transformation and are abundantly expressed in chronic inflammatory conditions which predispose to cancer. Components of the chemokine system affect multiple pathways of tumor progression including: leukocyte recruitment, neo-angiogenesis, tumor cell proliferation and survival, invasion and metastasis. Evidence in pre-clinical and clinical settings suggests that the chemokine system represents a valuable target for the development of innovative therapeutic strategies.
趋化因子是癌症相关炎症的关键参与者。趋化因子配体和受体是导致肿瘤转化的遗传事件的下游产物,在易患癌症的慢性炎症状态下大量表达。趋化因子系统的组成部分影响肿瘤进展的多个途径,包括:白细胞募集、新生血管生成、肿瘤细胞增殖和存活、侵袭和转移。临床前和临床研究证据表明,趋化因子系统是开发创新治疗策略的有价值的靶点。